News

The 2nd annual Avoca Quality Consortium (AQC) European Summit, which took place in Dublin, Ireland this year, prepared members for the new ICH E6 R2 guidelines which will be implemented across Europe on the 14th June 2017.

MIT researchers have engineered bacteria to respond to red, green or blue light, and can produce photographs in a dish. This engineered genetic logic opens up new opportunities for biologic development.

Partnership to provide a comprehensive, efficient workflow to enable library creation and data processing for Data-Independent Acquisition (DIA) studies.

Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have engineered a three-dimensional heart tissue from human stem cells to test the safety and efficacy of new drugs on the heart.

Checkmate 204 Trial Shows promising results in the treatment of metastatic melanoma.

ZCube, Research Venture of the pharmaceutical group Zambon, launches the second edition of Open Accelerator, a fast track acceleration program for life science start-up projects.

Sheryl joins Medherant as the Company prepares to start clinical studies with its first product, an ibuprofen patch.

NIAID sponsors clinical trial of Chikungunya vaccine

Antibodies from an Ebola survivor protected mice and ferrets against all three ebolaviruses that cause outbreaks in humans.

A newly published article offers advice to help scientists who study obesity, diabetes or other metabolic diseases better account for inherent sex differences in research.